Diabetes — We’ve got Answers to your Questions

 
logo
eBulletin   |   April 2015  
Diabetes - We've got Answers to your Questions
 
We are recognized for our expertise in complex trials, adaptive integrated designs and recruitment of special populations. To date, we have completed over 50 early stage trials involving anti-diabetic and hypoglycemic agents, including a single-center trial enrolling 75 Type I and Type II diabetic patients over four weeks.
 

The Question:
For Diabetic patients, what can you expect in terms of enrollment rate per month?

"Algorithme Pharma has repeatedly demonstrated a willingness to explore new areas and incorporate tools and technologies to execute new study designs. For example, they have embraced complicated protocols including using insulin to induce hypoglycemia and have welcomed outside expertise to help them further develop internal capabilities."

- Hélène Dulude, B.Pharm., Ph.D., Director, Clinical Development, Locemia Solutions ULC

The Answer:
Algorithme Pharma averages 30 new patients per month.

Through our database of participants, we have access to more than 750 Type l diabetic patients and over 1,500 patients with Type ll diabetes. We also recruit new participants through marketing and advertising campaigns using social media, radio and newspaper, within the greater Montreal area. Using a searchable database, we qualify inclusion/exclusion criteria, demographics and concomitant medication use.

 
More about our Diabetes therapeutic expertise »
 
 

Let's Talk!

Mira Francis, B.Pharm., Ph.D., MBA
Director, Medical Science Liaison in Phase I/II,
Scientific & Regulatory Affairs

450 973-6077 or 888 267-7449, ext. 2261
mfrancis@algopharm.com

 
 

 
 
 
 
©2015 All Rights Reserved, Algorithme Pharma inc., 2015